The effect of peritoneal dialysis of the pharmacokinetics of amikacin
Matzke, G.R.; Salem, N.; Bockbrader, H.; Blevins, R.
Proceedings of the Clinical Dialysis and Transplant Forum 10: 302-304
1980
ISSN/ISBN: 0094-6044 PMID: 7346850 Document Number: 167425
Document emailed within 1 workday
Related Documents
Tiberio López, G.; Unzué Gaztelu, J.J.; Antón Aranda, E.; Asín Marcotegui, J.L. 1985: Our experience in the treatment of peritonitis in ambulatory chronic peritoneal dialysis with mezlocillin and amikacin Medicina Clinica 85(14): 599-600Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Sica, D.A.; Yonce, C.; Small, R.; Cefali, E.; Harford, A.; Poynor, W. 1988: Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis International Journal of Clinical Pharmacology Therapy and Toxicology 26(2): 59-64
Poirier, J.M.; Joannides, R.; Geffroy-Josse, S.; Fillastre, J.P.; Etienne, I. 1992: Propafenone pharmacokinetics in uremic patients treated by peritoneal dialysis Clinical Nephrology 38(4): 231-232
Chan, M.K.; Chau, P.Y.; Chan, W.W. 1987: Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis Clinical Nephrology 28(6): 277-280
Halstenson, C.E.; Blevins, R.B.; Salem, N.G.; Matzke, G.R. 1984: Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis Clinical Nephrology 22(5): 239-243
Manley, H.J.; Bailie, G.R.; Asher, R.D.; Eisele, G.; Frye, R.F. 1999: Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(1): 65-70
Blackwell, B.G.; Leggett, J.E.; Johnson, C.A.; Zimmerman, S.W.; Craig, W.A. 1990: Ampicillin and sulbactam pharmacokinetics and pharmacodynamics in continuous ambulatory peritoneal dialysis (CAPD) Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 10(3): 221-226
De Mey, C.; Scharpe, S.; De Bock, R.; Bossaert, L. 1981: Predictive pharmacokinetics of amikacin using actually measured and assumed parameters, applied in 1-compartment linear pharmacokinetics Archives Internationales de Pharmacodynamie et de Therapie 253(2): 323-324
De Fijter, C.W.; Verbrugh, H.A.; Oe, P.L.; Peters, E.D.; van der Meulen, J.; Donker, A.J.; Verhoef, J.; Lameire, N. 1991: The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 7: 154-157
Zweers, M.M.; Splint, L.J.; Krediet, R.T.; Struijk, D.G. 2001: Effect of fluid supplementation and modality on peritoneal permeability characteristics in a rat peritoneal dialysis model Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(1): 58-64
Atkins, R.C.; Holdsworth, S.R.; Fitzgerald, M.G.; Hosking, C.S. 1978: The effect of maintenance dialysis on lymphocyte function. II. Peritoneal dialysis Clinical and Experimental Immunology 33(1): 102-106
Pawlaczyk, K.; Garcia-Lopez, E.; Kuzlan-Pawlaczyk, M.; Heimbürger, O.; Bergström, J.; Breborowicz, A.; Lindholm, B. 2001: The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(Suppl 3): S359-S361
Duan, S.; Liu, F.; Xiao, P.; Xia, J.; Peng, Y.; Ye, Y.; Luo, J. 2001: The effect of lactate-buffered peritoneal dialysis fluid in human peritoneal mesothelial cells function Zhonghua Nei Ke Za Zhi 40(7): 463-466
Opatrná, S.; Racek, J.; Stehlík, P.; Senft, V.; Sefrna, F.; Topolcan, O.; Opatrný, K. 2002: Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis Casopis Lekaru Ceskych 141(9): 281-285
Hutchison, A.J.; Ofsthun, N.J.; Howarth, D.; Gokal, R. 1992: The effect of hemoglobin concentration on peritoneal mass transfer and drain volumes in continuous ambulatory peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 12(2): 230-233
Jearnsujitwimol, V.; Eiam-Ong, S.; Kanjanabuch, T.; Wathanavaha, A.; Pansin, P. 2006: The effect of angiotensin Ii receptor blocker on peritoneal membrane transports in continuous ambulatory peritoneal dialysis patients Journal of the Medical Association of Thailand 89(Suppl 2): S188-S195
Günal, A.I.; Celiker, H.; Ustundag, B.; Akpolat, N.; Dogukan, A.; Akcicek, F. 2003: The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution Journal of Nephrology 16(2): 225-230
Sifil, A.; Mermut, C.; Yenicerioglu, Y.; Cavdar, C.; Gumustekin, M.; Celik, A.; Yuksel, F.; Camsari, T. 2003: Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 28-30
Pietrzak, I.; Baczyk, K.; Ksiazek, P. 1995: Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 50: 197-203